Evaluation of Amphetamine-Related Hospitalizations and Associated Clinical Outcomes and Costs in the United States | Zendy

Tyler N. A. Winkelman | Zendy; Lindsay K. Admon | Zendy; Latasha Jennings | Zendy; Nathan D. Shippee | Zendy; Caroline R. Richardson | Zendy; Gavin Bart | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Evaluation of Amphetamine-Related Hospitalizations and Associated Clinical Outcomes and Costs in the United States

Author(s) -

Tyler N. A. Winkelman,

Lindsay K. Admon,

Latasha Jennings,

Nathan D. Shippee,

Caroline R. Richardson,

Gavin Bart

Publication year - 2018

Publication title -

jama network open

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.278

H-Index - 39

ISSN - 2574-3805

DOI - 10.1001/jamanetworkopen.2018.3758

Subject(s) - medicine , amphetamine , medicaid , poisson regression , demography , healthcare cost and utilization project , residence , logistic regression , population , emergency medicine , pediatrics , health care , environmental health , sociology , economics , dopamine , economic growth

Key Points Question What are the current trends in frequency and costs of amphetamine-related hospitalizations in the United States? Findings In this cross-sectional study of approximately 1.3 million amphetamine-related US hospitalizations between 2003 and 2015, hospitalizations increased substantially by 2015, with the highest frequency being in the western United States and the predominant payer being Medicaid. Meaning Amphetamine use may be an emerging public health issue; pharmacologic and nonpharmacologic therapies that effectively treat amphetamine use disorder are needed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research